Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study

BMC Medical Imaging

Table 2 Results

Patient	Aortic valve type CMR	Aortic valve type surgery	AVA in vivo by CMR (cm²)	AVA ex vivo by CMR (cm²)	AVA by TEE (cm²)	AVA by TTE (cm²)	AVA by CATH (cm²)	PG mean by Doppler (mmHg)	PG mean by CATH (mmHg)	LV EF by CMR (%)	LV Mass by CMR (g)	LV SV by CMR (ml)
1	BAV	BAV	0.84	0.76	-	0.74	0.29	65	77	50	151	61
2	TAV	TAV	0.70	0.55	0.65	0.65	0.36	59	65	41	126	36
3	TAV	TAV	0.84	0.73	0.70	0.75	0.64	53	45	81	177	81
4	TAV	TAV	0.86	0.70	0.80	0.75	0.52	76	76	59	178	73
5	TAV	TAV	0.62	0.50	0.70	0.55	0.34	44	46	19	134	40
6	BAV	BAV	0.76	0.69	1.10	0.65	0.85	40	35	45	210	72
7	TAV	TAV	0.72	0.68	0.75	0.73	0.67	49	55	77	113	57
8	TAV	TAV	0.71	0.59	0.80	0.69	1.08	30	20	71	120	50

AVA, aortic valve area; BAV, bicuspid aortic valve; CMR, cardiovascular magnetic resonance; CATH, cardiac catheterization; TEE, transesophageal echocardiography; TTE, transthoracic echocardiography; LV EF, left ventricular ejection fraction; LV mass, left ventricular mass; LV SV, left ventricular stroke volume; PG, pressure gradient; TAV, tricuspid aortic valve

ISSN: 1471-2342